期刊文献+

血清胱抑素C、C反应蛋白和尿β2-微球蛋白联合检测在2型糖尿病肾病诊断中的价值 被引量:6

Combined examination of serum cystatin C, C reactive protein, and β-2 urine microglobulin for diagnosing type 2 diabetic nephropathy
下载PDF
导出
摘要 目的 探讨血清胱抑素C (Cys C)、C反应蛋白(CRP)及尿β 2微球蛋白(β 2-MG)联合检测在2型糖尿病肾病(diabetic nephropathy,DN)诊断中的临床应用价值.方法 选择我院111例2型糖尿病患者为研究对象,根据患者尿白蛋白排泄率(UAER)分为三组:B组为正常蛋白尿组42例(UAER<20μg/min),C组为微量蛋白尿组33例(20μg/min≤UAER≤200μg/min),D组为大量蛋白尿组36例(UAER>200μg/min);同时选择40例健康者作为对照组(A组).测定各组血CysC、CRP和尿β 2-MG,应用Pearson's相关性分析检测各指标与UAER的关系,受试者工作特征(ROC)曲线测试各指标及联合检测检效能.结果 DN患者Cys C、CRP和尿β 2-MG明显高于对照组(P<0.05);糖尿病患者Cys C、CRP和尿β 2-MG水平与UAER呈显著正相关(r分别为0.65、0.46、0.53,P<0.05);CysC、CRP和尿β 2-MG联合诊断的ROC曲线下面积大于各指标单独诊断.结论 糖尿病患者血CysC、CRP和尿β 2-MG水平的升高与其早期肾损伤的发生密切相关,联合应用可以提高DN早期肾损伤诊断的准确性. Objective To investigate the clinical value of the combined examination of serum Cystatin C (Cys C),C reactive protein (CRP),and β-2 urine microglobulin (β 2-MG) in the diagnosis of type 2 diabetic nephropathy (DN).Methods 141 patients with diabetes mellitus (DM) from our hospital were divided into 3 groups according to urinary albumin excretion rate (UAER):42 cases in group B (UAER < 20 μg/min),33 cases in group C (20 μ g/min ≤ UAER ≤ 200 μ g/min),and 36 cases in group D (UAER > 200 tμ g/min).40 health persons without DM were seslected a control group (group A).The serum Cys C,CRP,and urine β 2-MG concentrations were measured in each group.The relationship between UAER and each indicator was evaluated by pearson' s correlation analysis,and the efficiencies of each indicator and combination examination were evaluated by ceiver operating characteristic (ROC) curve analysis.Results The Cys C,CRP,and β 2-MG concentrations were statistically higher in the DN patients than in the control group (P < 0.05) and were higher in group C and D than in group B (P < 0.05).In DM patients,Cys C,CRP,and β 2-MG positively correlated with UAER (r =0.65,0.46,0.53,respectively,P < 0.05).ROC areas of combined examination were larger than that of each indicator.Conclusions Cys C,CRP,and β 2-MG are sensitive indicators for early diagnosing DN.Combined examination can improve the accuracy of the early diagnosis of DN.
作者 谢传珍
出处 《国际医药卫生导报》 2014年第10期1422-1425,共4页 International Medicine and Health Guidance News
关键词 胱抑素C C反应蛋白 尿Β2微球蛋白 糖尿病肾病 Cystatin C C reactive protein β-2 urine microglobulin Diabetic nephropathy
  • 相关文献

参考文献15

  • 1翁建平.糖尿病肾病的诊断与治疗[J].临床内科杂志,2005,22(3):150-153. 被引量:79
  • 2Ekberg G, Grefberg N, Larsson O, et al. Relation between serum cholesterol and diabetic nephropathy[J]. Lancet, 1990, 336 (8720) : 954.
  • 3Shimizu A, Horikoshi S, Rinnno H, et al. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy[J]. J Clin Lab Anal, 2003, 17 (5) : 164-167.
  • 4冯文忠,安云,张仁虎.CTGF,胱抑素C和尿β2-MG联合检测在糖尿病肾病早期病变中的诊断价值[J].现代检验医学杂志,2013,28(2):96-98. 被引量:12
  • 5Abrahamian H, Endler G, Exner M, et al. Association of low-grade inflammation with nephropathy in type 2 diabetic patients : role of elevated CRP-levels and 2 different gene- polymorphisms of proinflammatory cytokines[J]. Exp Clin Endocrinol Diabetes, 2007, 115 ( 1 ) : 38-41.
  • 6杨莉亚,刘必成.糖尿病肾病诊断生物标志物研究新进展[J].东南大学学报(医学版),2010,29(4):469-472. 被引量:11
  • 7Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, et al. Features of endothelial dysfunction in early diabetic nephropathy[J]. Lancet, 1989, 1 (8636) : 461-463.
  • 8Pavkov ME, Knowler WC, Hanson RL, et al. Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failurein American Indians with diabetic nephropathy[J]. Am J Kidney Dis, 2013, 62 (1) : 33-41.
  • 9Christensson AG, Grubb AO, Nilsson JA, et al. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy[J]. J Intern Med, 2004, 256 (6) : 510-518.
  • 10黄烈虎,叶荣,林晰敏.缬沙坦和洛汀新对糖尿病肾病患者尿α_1-MG及β_2-MG的影响[J].国际医药卫生导报,2004,10(8):51-52. 被引量:1

二级参考文献86

共引文献156

同被引文献46

  • 1美国NKF-K/DOQI工作组 王海燕 王梅主译.慢性肾脏病及透析的临床实践指南[M].北京:人民卫生出版社,2003.118,124,279,375-379,397-402.
  • 2张霞,孟静,罗伟.新诊断妊娠期糖尿病患者检测尿微量白蛋白的临床意义[J].中国优生与遗传杂志,2007,15(10):42-42. 被引量:6
  • 3谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 4Grubb AO.Cystatin C--properties and use as diagnostic marker[J].Adv Clin Chem, 2000, 35: 63-99.
  • 5Tenstad O, Roald AB, Crubh A, et al. Renal handling of radiolabelled human cystatin C in the rat[J].Scand J Clin Lab Invest, 1996, 56(5): 409-414.
  • 6Zahran A, El-Husseini A, Shokcr A. Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review[J]. AmJNephrol, 2007, 27(2): 197-205.
  • 7Strevens H, Wide-Swensson D, Grubb A, et al. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre- eclamoticvregnancies[Jl.BJOG, 2003, 110(9): 825-830.
  • 8Borges RL, Hirota AH, Quinto BM, et al. Is cystatin C a useful marker in the detection of diabetic kidney disease?[J].Nephron Clin Pract, 2010, 114(2): 127-134.
  • 9Bokenkamp A, van Wijk JA, Lentze M J, et al. Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations[J]. Clin Chem, 2002, 48(7): 1123-1126.
  • 10Li,K.,Yu,L.,Liu,X,et al.A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel[J].Biomaterials,2013,34(11):2834-2842.

引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部